Clinical trials often lack diversity; revising eligibility rules may help, researchers say

By FYH News Team

Published on April 17, 2022

[ad_1]

Excluding people based on medical conditions unintentionally contributes to the underrepresentation of racial groups
Historically, participants of clinical trials have mostly been white men. Racism, distrust of the health care system, lack of diversity among health care providers and lack of access to proper health care all are factors that contribute to…

Read Full Story

If the content contained herein violates any of your rights, including those of copyright, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com

U.S

Top News

comments

Load app to read more comments

[ad_2]

Source link

Features

Download and distribute powerful vaccination QI resources for your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.